SlideShare a Scribd company logo
1 of 11
PHYSICAL PROPERTIES OF PRE-
FORMULATION STUDY
Presented By:
Rahul Pal, Prachi Pandey
M. Pharm (Pharmaceutics)
Department of Pharmaceutics
NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan, India
PRE-FORMULATION
 It is define as the phase of research and development in which pre-
formulation studies characterized physical and chemical properties of a
drug in order to develop safe, effective and stable dosages form.
PHYSICAL PROPERTIES OF PRE-
FORMULATION
 Particle form
 Particle size
 Particle shape
 Flow properties
 Stability profile (pKa , pH, partial coefficient)
 Polymorphism
PARTICLE FORM
 Solid is one of the three classical states of matter. It is characterised by the
structural rigidity and resistance to changes in shape or volume . A solid
molecule is made up of atoms tightly bound to each other either in a
regular geometric lattice or irregularly. It could be divided two type.
 Crystalline
 Amorphous
PARTICLE SIZE
 Particle size is characterised to express the geometrical shape and surface
regularity of the material. Moreover, particle shape affected the surface area,
flow, packing and compaction properties of particle.
 The particle shape either spherical or asymmetrical can be determined.in order
to differentiate the shape of spherical or asymmetrical objects, it is necessary to
know that the sphere has minimum surface area per unit volume.
FLOW PROPERTIES
 Powder flows properties can be affected by change in particle size, shape and
density.
 The flows properties depend upon following:-
• Force of friction
• Cohesion between one particle to another
 Fine particle posses poor flow by filling void spaces between larger particle causing
packing & densification of particle.
 By using glidant we can alter the flow properties e.g. talc.
SOLUBILITY PROFILE
 The drug-solvent systems through which the drug is delivered helps in the
pre-formulation solubility studies. For example, solubility of an orally
administered drug in media with isotonic chloride ion concentration and
acidic pH can be determined.
 The administration route are not clearly defined at this point, still the
formulation work can be carried out by understanding the solubility profile
of the drug and mechanism of solubility.
pH AND PKa SOLUBILITY PROFILE
 Determination of pKa: The Henderson-Hasseslebalch provides an estimate
of the ionised & unionised drug concentration at a particular pH.
for acidic drugs,
pH= pKa + log(ionised drug/unionised drug)
for basic drugs,
pH= pKa+ log(ionised drug/unionised drug)
 Buffers, temperature, ionic strength and cosolvent can affect the pKa value.
PARTIAL COEFFICIENT
 Partition coefficient is defined, as the ratio of un-ionised drug
concentrations between the organic and aqueous phases, at
equilibrium.
 Generally ,2-octanol and chloroform are taken as the oil phase. M
equilibrium.
POLYMORPHISM
 When a substance is in more than one crystalline form, the various forms
are called polymorphs and the phenomenon as polymorphism.
 For example- chloramphenicol palmitate has three polymorphs A, B and
C. spironolactone exhibits 6 polymorphs.
THANK YOU

More Related Content

Similar to Physical Properties of Pre-formulation.pptx

Preformulation study
Preformulation studyPreformulation study
Preformulation studyNikitaGidde
 
Preformulation and physicochemical property of the drug
Preformulation and physicochemical property of the drugPreformulation and physicochemical property of the drug
Preformulation and physicochemical property of the drugSHIVANEE VYAS
 
Preformulation unit i uips (2)
Preformulation unit i uips (2)Preformulation unit i uips (2)
Preformulation unit i uips (2)Tarun Parashar
 
Preformulation Power Point Presentation
Preformulation Power Point PresentationPreformulation Power Point Presentation
Preformulation Power Point PresentationBHAGYASHRI BHANAGE
 
Pharmaceutical preformulation's
Pharmaceutical preformulation'sPharmaceutical preformulation's
Pharmaceutical preformulation'sSunil Boreddy Rx
 
Preformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulationPreformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulationM R S
 
preformulation studies by SeDeM expert system tool
preformulation studies by SeDeM expert system toolpreformulation studies by SeDeM expert system tool
preformulation studies by SeDeM expert system toolNagabhushanShet4
 
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptxPREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptxSWASTIKPATNAIK1
 
Preformulation study by Pavan B Zalte
Preformulation  study by Pavan B ZaltePreformulation  study by Pavan B Zalte
Preformulation study by Pavan B ZaltePavanZalte2
 
Preformulation Studies by Jayesh Anil Mahirrao
Preformulation Studies by Jayesh Anil MahirraoPreformulation Studies by Jayesh Anil Mahirrao
Preformulation Studies by Jayesh Anil MahirraoJayesh Mahirrao
 
Medicinal chemistry -l-Second year-Fourth semester -medichem physicochemical ...
Medicinal chemistry -l-Second year-Fourth semester -medichem physicochemical ...Medicinal chemistry -l-Second year-Fourth semester -medichem physicochemical ...
Medicinal chemistry -l-Second year-Fourth semester -medichem physicochemical ...manjusha kareppa
 

Similar to Physical Properties of Pre-formulation.pptx (20)

Preformation supriya
Preformation supriyaPreformation supriya
Preformation supriya
 
Preformulation study
Preformulation studyPreformulation study
Preformulation study
 
Preformulation and physicochemical property of the drug
Preformulation and physicochemical property of the drugPreformulation and physicochemical property of the drug
Preformulation and physicochemical property of the drug
 
Preformulation unit i uips (2)
Preformulation unit i uips (2)Preformulation unit i uips (2)
Preformulation unit i uips (2)
 
Preformulation Power Point Presentation
Preformulation Power Point PresentationPreformulation Power Point Presentation
Preformulation Power Point Presentation
 
Preformulation
PreformulationPreformulation
Preformulation
 
Preformulation
PreformulationPreformulation
Preformulation
 
Umesh bhandari
Umesh bhandariUmesh bhandari
Umesh bhandari
 
Preformulation Guide
Preformulation GuidePreformulation Guide
Preformulation Guide
 
Pharmaceutical preformulation's
Pharmaceutical preformulation'sPharmaceutical preformulation's
Pharmaceutical preformulation's
 
Preformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulationPreformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulation
 
preformulation studies by SeDeM expert system tool
preformulation studies by SeDeM expert system toolpreformulation studies by SeDeM expert system tool
preformulation studies by SeDeM expert system tool
 
Preformultion study.pptx
Preformultion study.pptxPreformultion study.pptx
Preformultion study.pptx
 
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptxPREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
 
Preformulation study by Pavan B Zalte
Preformulation  study by Pavan B ZaltePreformulation  study by Pavan B Zalte
Preformulation study by Pavan B Zalte
 
preformulation
preformulationpreformulation
preformulation
 
Preformulation
PreformulationPreformulation
Preformulation
 
Preformulation Studies by Jayesh Anil Mahirrao
Preformulation Studies by Jayesh Anil MahirraoPreformulation Studies by Jayesh Anil Mahirrao
Preformulation Studies by Jayesh Anil Mahirrao
 
Medicinal chemistry -l-Second year-Fourth semester -medichem physicochemical ...
Medicinal chemistry -l-Second year-Fourth semester -medichem physicochemical ...Medicinal chemistry -l-Second year-Fourth semester -medichem physicochemical ...
Medicinal chemistry -l-Second year-Fourth semester -medichem physicochemical ...
 
PREFORMULATION STUDY
PREFORMULATION STUDYPREFORMULATION STUDY
PREFORMULATION STUDY
 

More from Prachi Pandey

Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxPrachi Pandey
 
Niosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptxNiosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptxPrachi Pandey
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...Prachi Pandey
 
The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...Prachi Pandey
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...Prachi Pandey
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfPrachi Pandey
 
Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)Prachi Pandey
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPrachi Pandey
 
Partition Coefficient Determination.pptx
Partition Coefficient Determination.pptxPartition Coefficient Determination.pptx
Partition Coefficient Determination.pptxPrachi Pandey
 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Prachi Pandey
 
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Prachi Pandey
 
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...Prachi Pandey
 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Prachi Pandey
 
ProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptxProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptxPrachi Pandey
 
MicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptxMicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptxPrachi Pandey
 
Protein and Peptide.pptx
Protein and Peptide.pptxProtein and Peptide.pptx
Protein and Peptide.pptxPrachi Pandey
 
NanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdfNanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdfPrachi Pandey
 
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptxTOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptxPrachi Pandey
 
IntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxIntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxPrachi Pandey
 

More from Prachi Pandey (20)

Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
 
Niosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptxNiosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptx
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...
 
The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
 
Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
 
Partition Coefficient Determination.pptx
Partition Coefficient Determination.pptxPartition Coefficient Determination.pptx
Partition Coefficient Determination.pptx
 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
 
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
 
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
 
ProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptxProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptx
 
IMPORTSOFDRUGS.pptx
IMPORTSOFDRUGS.pptxIMPORTSOFDRUGS.pptx
IMPORTSOFDRUGS.pptx
 
MicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptxMicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptx
 
Protein and Peptide.pptx
Protein and Peptide.pptxProtein and Peptide.pptx
Protein and Peptide.pptx
 
NanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdfNanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdf
 
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptxTOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
 
IntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxIntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptx
 

Recently uploaded

Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 

Recently uploaded (20)

Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 

Physical Properties of Pre-formulation.pptx

  • 1. PHYSICAL PROPERTIES OF PRE- FORMULATION STUDY Presented By: Rahul Pal, Prachi Pandey M. Pharm (Pharmaceutics) Department of Pharmaceutics NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan, India
  • 2. PRE-FORMULATION  It is define as the phase of research and development in which pre- formulation studies characterized physical and chemical properties of a drug in order to develop safe, effective and stable dosages form.
  • 3. PHYSICAL PROPERTIES OF PRE- FORMULATION  Particle form  Particle size  Particle shape  Flow properties  Stability profile (pKa , pH, partial coefficient)  Polymorphism
  • 4. PARTICLE FORM  Solid is one of the three classical states of matter. It is characterised by the structural rigidity and resistance to changes in shape or volume . A solid molecule is made up of atoms tightly bound to each other either in a regular geometric lattice or irregularly. It could be divided two type.  Crystalline  Amorphous
  • 5. PARTICLE SIZE  Particle size is characterised to express the geometrical shape and surface regularity of the material. Moreover, particle shape affected the surface area, flow, packing and compaction properties of particle.  The particle shape either spherical or asymmetrical can be determined.in order to differentiate the shape of spherical or asymmetrical objects, it is necessary to know that the sphere has minimum surface area per unit volume.
  • 6. FLOW PROPERTIES  Powder flows properties can be affected by change in particle size, shape and density.  The flows properties depend upon following:- • Force of friction • Cohesion between one particle to another  Fine particle posses poor flow by filling void spaces between larger particle causing packing & densification of particle.  By using glidant we can alter the flow properties e.g. talc.
  • 7. SOLUBILITY PROFILE  The drug-solvent systems through which the drug is delivered helps in the pre-formulation solubility studies. For example, solubility of an orally administered drug in media with isotonic chloride ion concentration and acidic pH can be determined.  The administration route are not clearly defined at this point, still the formulation work can be carried out by understanding the solubility profile of the drug and mechanism of solubility.
  • 8. pH AND PKa SOLUBILITY PROFILE  Determination of pKa: The Henderson-Hasseslebalch provides an estimate of the ionised & unionised drug concentration at a particular pH. for acidic drugs, pH= pKa + log(ionised drug/unionised drug) for basic drugs, pH= pKa+ log(ionised drug/unionised drug)  Buffers, temperature, ionic strength and cosolvent can affect the pKa value.
  • 9. PARTIAL COEFFICIENT  Partition coefficient is defined, as the ratio of un-ionised drug concentrations between the organic and aqueous phases, at equilibrium.  Generally ,2-octanol and chloroform are taken as the oil phase. M equilibrium.
  • 10. POLYMORPHISM  When a substance is in more than one crystalline form, the various forms are called polymorphs and the phenomenon as polymorphism.  For example- chloramphenicol palmitate has three polymorphs A, B and C. spironolactone exhibits 6 polymorphs.